During the past decade, Allergie-Centrum-Charité conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergie-Centrum-Charité" #1 sponsor was "Charite University, Berlin, Germany" with 4 trials, followed by "Stallergenes Greer" with 2 trials sponsored, "Artu Biologicals" with 1 trials sponsored, "Leti Pharma GmbH" with 1 trials sponsored and "Shire" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergie-Centrum-Charité" #1 collaborator was "Aptuit" with 1 trials as a collaborator, "Cenduit LLC" with 1 trials as a collaborator, "Essex Pharma GmbH" with 1 trials as a collaborator, "Labor Dr. Spranger (Central lab)" with 1 trials as a collaborator and "Laboratorios LETI SL (Study Medication)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Allergie-Centrum-Charité" are "Chronic Urticaria" (4 trials), "Allergic Conjunctivitis" (1 trials), "Allergic Rhinitis" (1 trials), "Allergic Rhinitis and/or Rhinoconjunctivitis +- Asthma" (1 trials) and "Allergic Rhinoconjunctivitis" (1 trials). Many other conditions were trialed in "Allergie-Centrum-Charité" in a lesser frequency.

Most popular intervention types in "Allergie-Centrum-Charité" are "Biological" (3 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "10 mg Rupatadine" (1 trials), "10 mg Rupatadine on demand" (1 trials), "10 mg Rupatadine on demand (sham updosing to 20 mg)" (1 trials), "20 mg Rupatadine" (1 trials) and "Allergoid, allergenic extract of 100% Birch" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergie-Centrum-Charité" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Allergie-Centrum-Charité". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Allergie-Centrum-Charité, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Allergie-Centrum-Charité, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".